Table 1.
Demographic information for the study cohort.
| EGFR (+) | ALK (+) | KRAS (+) | p-value | |
|---|---|---|---|---|
| N = 75 | N = 21 | N = 15 | ||
| Age | ||||
| Mean ± SD | 57.43 ± 12.09 | 53.81 ± 14.79 | 63.67 ± 6.40 | 0.09 |
| Race | ||||
| Caucasian | 34 (45.33%) | 13(61.90%) | 11 (73.33%) | |
| Asian | 35 (46.67%) | 7 (33.33%) | 1 (6.67%) | 0.016 |
| Other1 | 6 (8%) | 1 (0.04%) | 3 (20%) | |
| Gender | ||||
| Male | 24 (32%) | 8 (38.10%) | 5 (33.33%) | 0.83 |
| Female | 51 (68%) | 13 (61.90%) | 10 (66.67%) | |
| History of Smoking | ||||
| Yes | 20 (26.67%) | 5 (23.80%) | 12 (80%) | <0.001 |
| No | 55 (73.33%) | 16 (76.19%) | 3 (20%) |
1
American Indian or Alaska Native, African American, Native Hawaiian, or Pacific Islander.
EGFR, epidermal growth factor receptor; ALK, anaplastic lymphoma kinase; KRAS, Kirsten rat sarcoma viral oncogene homolog.